脑啡肽酶(CD10)检测试剂盒(酶联免疫吸附试验法)
ELISA Kit for Neprilysin (CD10)
NEP; MME; CALLA; SFE; Atriopeptidase; Enkephalinase; Skin fibroblast elastase; Common Acute Lymphoblastic Leukemia Antigen; Membrane Metallo-Endopeptidase
- 编号SEB785Hu
- 物种Homo sapiens (Human,人) 相同的名称,不同的物种。
- 实验方法双抗夹心
- 反应时长3h
- 检测范围31.2-2,000pg/mL
- 灵敏度最小可检测剂量小于等于12.5pg/mL.
- 样本类型serum, plasma, cerebrospinal fluid and other biological fluids
- 下载 英文说明书 中文说明书
- 规格 48T96T 96T*5 96T*10 96T*100
- 价格 ¥ 2793 ¥ 3990 ¥ 17955 ¥ 33915 ¥ 279300
- 欲了解实际交易价格和更多情况,请与当地经销商联系!
特异性
本试剂盒用于检测脑啡肽酶(CD10),经检测与其它相似物质无明显交叉反应。
由于受到技术及样本来源的限制,不可能完成对所有相关或相似物质交叉反应检测,因此本试剂盒有可能与未经检测的其它物质有交叉反应。
回收率
分别于定值血清及血浆样本中加入一定量的脑啡肽酶(CD10)(加标样品),重复测定并计算其均值,回收率为测定值与理论值的比率。
样本 | 回收率范围(%) | 平均回收率(%) |
serum(n=5) | 80-98 | 89 |
EDTA plasma(n=5) | 85-104 | 97 |
heparin plasma(n=5) | 81-96 | 85 |
精密度
精密度用样品测定值的变异系数CV表示。CV(%) = SD/mean×100
批内差:取同批次试剂盒对低、中、高值定值样本进行定量检测,每份样本连续测定20 次,分别计算不同浓度样本的平均值及SD值。
批间差:选取3个不同批次的试剂盒分别对低、中、高值定值样本进行定量测定,每个样本使用同一试剂盒重复测定8次,分别计算不同浓度样本的平均值及SD值。
批内差: CV<10%
批间差: CV<12%
线性
在定值血清及血浆样本内加入适量的脑啡肽酶(CD10),并倍比稀释成1:2,1:4,1:8,1:16的待测样本,线性范围即为稀释后样本中脑啡肽酶(CD10)含量的测定值与理论值的比率。
样本 | 1:2 | 1:4 | 1:8 | 1:16 |
serum(n=5) | 78-104% | 90-99% | 82-94% | 98-105% |
EDTA plasma(n=5) | 86-94% | 78-102% | 84-101% | 80-103% |
heparin plasma(n=5) | 78-92% | 91-98% | 91-105% | 79-102% |
稳定性
经测定,试剂盒在有效期内按推荐温度保存,其活性降低率小于5%。
为减小外部因素对试剂盒破坏前后检测值的影响,实验室的环境条件需尽量保持一致,尤其是实验室内温度、湿度及温育条件。其次由同一实验员来进行操作可减少人为误差。
实验流程
1. 实验前标准品、试剂及样本的准备;
2. 加样(标准品及样本)100µL,37°C孵育1小时;
3. 吸弃,加检测溶液A100µL,37°C孵育1小时;
4. 洗板3次;
5. 加检测溶液B100µL,37°C孵育30分钟;
6. 洗板5次;
7. 加TMB底物90µL,37°C孵育10-20分钟;
8. 加终止液50µL,立即450nm读数。
实验原理
将脑啡肽酶(CD10)抗体包被于96孔微孔板中,制成固相载体,向微孔中分别加入标准品或标本,其中的脑啡肽酶(CD10)与连接于固相载体上的抗体结合,然后加入生物素化的脑啡肽酶(CD10)抗体,将未结合的生物素化抗体洗净后,加入HRP标记的亲和素,再次彻底洗涤后加入TMB底物显色。TMB在过氧化物酶的催化下转化成蓝色,并在酸的作用下转化成最终的黄色。颜色的深浅和样品中的脑啡肽酶(CD10)呈正相关。用酶标仪在450nm波长下测定吸光度(O.D.值),计算样品浓度。
增值服务
相关产品
编号 | 适用物种:Homo sapiens (Human,人) | 应用(仅供研究使用,不用于临床诊断!) |
APB785Hu61 | 脑啡肽酶(CD10)活性蛋白 | Cell culture; Activity Assays. |
RPB785Hu02 | 脑啡肽酶(CD10)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB785Hu01 | 脑啡肽酶(CD10)重组蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPB785Hu61 | 脑啡肽酶(CD10)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB785Hu01 | 脑啡肽酶(CD10)多克隆抗体 | WB; IHC; ICC; IP. |
PAB785Hu02 | 脑啡肽酶(CD10)多克隆抗体 | WB; IHC; ICC; IP. |
LAB785Hu71 | 脑啡肽酶(CD10)多克隆抗体(生物素标记) | WB; IHC; ICC. |
MAB785Hu21 | 脑啡肽酶(CD10)单克隆抗体 | WB; IHC; ICC; IP. |
MAB785Hu23 | 脑啡肽酶(CD10)单克隆抗体 | WB; IHC; ICC; IP. |
MAB785Hu24 | 脑啡肽酶(CD10)单克隆抗体 | WB; IHC; ICC; IP. |
MAB785Hu22 | 脑啡肽酶(CD10)单克隆抗体 | WB; IHC; ICC; IP. |
MAB785Hu25 | 脑啡肽酶(CD10)单克隆抗体 | WB; IHC; ICC; IP. |
MAB785Hu27 | 脑啡肽酶(CD10)单克隆抗体 | WB; IHC; ICC; IP. |
MAB785Hu29 | 脑啡肽酶(CD10)单克隆抗体 | WB; IHC; ICC; IP. |
MAB785Hu26 | 脑啡肽酶(CD10)单克隆抗体 | WB; IHC; ICC; IP. |
FAB785Hu02 | 抗脑啡肽酶(CD10)单克隆抗体 | FCM |
FAB785Hu04 | 抗脑啡肽酶(CD10)单克隆抗体 | FCM |
FAB785Hu06 | 抗脑啡肽酶(CD10)单克隆抗体 | FCM |
FAB785Hu08 | 抗脑啡肽酶(CD10)单克隆抗体 | FCM |
FAB785Hu00 | 抗脑啡肽酶(CD10)单克隆抗体 | Flow cytometry. |
FAB785Hu82 | 抗脑啡肽酶(CD10)单克隆抗体(异硫氰酸荧光素标记) | FCM |
SEB785Hu | 脑啡肽酶(CD10)检测试剂盒(酶联免疫吸附试验法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB785Hu | 脑啡肽酶(CD10)等多因子检测试剂盒(流式荧光发光法) | FLIA Kit for Antigen Detection. |
参考文献
杂志 | 参考文献 |
13 | Elevated Plasma levels of Neutral Endpeptidase in Hypertension Patients Treated with Angiotensin Converting Enzyme Inhibitors [Ahajournals:Source] |
Biol Pharm Bull | Effect of High Glucose Levels on Amyloid β Production in Retinas of Spontaneous Diabetes Mellitus Otsuka Long-Evans Tokushima Fatty Rats [PubMed: 25832640] |
Eur J Heart Fail. | Soluble neprilysin does not correlate with outcome in heart failure with preserved ejection fraction [Pubmed:26725876] |
8 | A Test in Context: Neprilysin: Function, Inhibition, and Biomarker. [pubmed:27491909] |
European Journal of Heart Failure | Effects of sacubitril/valsartan on neprilysin targets and the metabolism of natriuretic peptides in chronic heart failure: a mechanistic clinical study [Pubmed: 30520545] |
European Journal of Heart Failure | Increased granulocyte membrane neprilysin (CD10) expression is associated with better prognosis in heart failure [Pubmed: 30828920] |
Clinical Research in Cardiology | Soluble neprilysin, NT-proBNP, and growth differentiation factor-15 as biomarkers for heart failure in dialysis patients (SONGBIRD) [Pubmed: 32002632] |
Neurotoxicology | Involvement of hippocampal agmatine in β1-42 amyloid induced memory impairment, neuroinflammation and BDNF signaling disruption in mice [Pubmed: 32522471] |
European Heart Journal | P1620 Association of granulocyte neprilysin (CD10) expression with prognosis in heart failure with reduced ejection fraction [] |
Clin Biochem | Finding a reliable assay for soluble neprilysin [Pubmed:35331754] |
Scientific Reports | The potential role of serum tau protein (MAPT), neuronal cell adhesion molecule (NrCAM) and neprilysin (NEP) in neurodegenerative disorders development in … [] |